Preclinical Development of Antibody-Drug Conjugate-Based Therapeutics for Cancer Treatment
Preclinical Development of Antibody-Drug Conjugate-Based Therapeutics for Cancer Treatment
Alle 12.30 Gianluca Sala, PhD in Oncologia e Patologia, Senior Scientist e Lecturer presso l'Univ